Logo image of HLBN.DE

HOLCIM LTD (HLBN.DE) Stock Fundamental Analysis

FRA:HLBN - CH0012214059 - Common Stock

71.46 EUR
+0.66 (+0.93%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

6

HLBN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 13 industry peers in the Construction Materials industry. HLBN has an excellent profitability rating, but there are some minor concerns on its financial health. HLBN has a valuation in line with the averages, but on the other hand it scores bad on growth. Finally HLBN also has an excellent dividend rating. These ratings could make HLBN a good candidate for dividend investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

HLBN had positive earnings in the past year.
HLBN had a positive operating cash flow in the past year.
Each year in the past 5 years HLBN has been profitable.
In the past 5 years HLBN always reported a positive cash flow from operatings.
HLBN.DE Yearly Net Income VS EBIT VS OCF VS FCFHLBN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

HLBN has a better Return On Assets (46.72%) than 100.00% of its industry peers.
HLBN's Return On Equity of 105.31% is amongst the best of the industry. HLBN outperforms 100.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 10.52%, HLBN belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for HLBN is in line with the industry average of 8.11%.
The 3 year average ROIC (6.46%) for HLBN is below the current ROIC(10.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 46.72%
ROE 105.31%
ROIC 10.52%
ROA(3y)5.62%
ROA(5y)4.77%
ROE(3y)11.3%
ROE(5y)9.72%
ROIC(3y)6.46%
ROIC(5y)6.04%
HLBN.DE Yearly ROA, ROE, ROICHLBN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

HLBN's Profit Margin of 71.83% is amongst the best of the industry. HLBN outperforms 100.00% of its industry peers.
In the last couple of years the Profit Margin of HLBN has grown nicely.
HLBN has a better Operating Margin (17.33%) than 84.62% of its industry peers.
In the last couple of years the Operating Margin of HLBN has grown nicely.
With a Gross Margin value of 44.69%, HLBN is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
HLBN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.33%
PM (TTM) 71.83%
GM 44.69%
OM growth 3Y4.25%
OM growth 5Y6.16%
PM growth 3Y9.2%
PM growth 5Y5.79%
GM growth 3Y0.94%
GM growth 5Y0.93%
HLBN.DE Yearly Profit, Operating, Gross MarginsHLBN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so HLBN is creating value.
HLBN has less shares outstanding than it did 1 year ago.
HLBN has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, HLBN has an improved debt to assets ratio.
HLBN.DE Yearly Shares OutstandingHLBN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
HLBN.DE Yearly Total Debt VS Total AssetsHLBN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

HLBN has an Altman-Z score of 3.73. This indicates that HLBN is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of HLBN (3.73) is better than 84.62% of its industry peers.
HLBN has a debt to FCF ratio of 2.67. This is a good value and a sign of high solvency as HLBN would need 2.67 years to pay back of all of its debts.
The Debt to FCF ratio of HLBN (2.67) is better than 76.92% of its industry peers.
HLBN has a Debt/Equity ratio of 0.62. This is a neutral value indicating HLBN is somewhat dependend on debt financing.
HLBN's Debt to Equity ratio of 0.62 is on the low side compared to the rest of the industry. HLBN is outperformed by 84.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 2.67
Altman-Z 3.73
ROIC/WACC2.31
WACC4.56%
HLBN.DE Yearly LT Debt VS Equity VS FCFHLBN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

HLBN has a Current Ratio of 1.49. This is a normal value and indicates that HLBN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.49, HLBN perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
A Quick Ratio of 1.21 indicates that HLBN should not have too much problems paying its short term obligations.
HLBN has a Quick ratio (1.21) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 1.21
HLBN.DE Yearly Current Assets VS Current LiabilitesHLBN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 422.14% over the past year.
HLBN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.24% yearly.
Looking at the last year, HLBN shows a very negative growth in Revenue. The Revenue has decreased by -19.77% in the last year.
HLBN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.24% yearly.
EPS 1Y (TTM)422.14%
EPS 3Y11.85%
EPS 5Y7.24%
EPS Q2Q%1046.3%
Revenue 1Y (TTM)-19.77%
Revenue growth 3Y-0.53%
Revenue growth 5Y-0.24%
Sales Q2Q%-38.57%

3.2 Future

The Earnings Per Share is expected to decrease by -5.57% on average over the next years.
Based on estimates for the next years, HLBN will show a decrease in Revenue. The Revenue will decrease by -6.41% on average per year.
EPS Next Y-39.97%
EPS Next 2Y-20.13%
EPS Next 3Y-10.87%
EPS Next 5Y-5.57%
Revenue Next Year-38.75%
Revenue Next 2Y-20.44%
Revenue Next 3Y-12.87%
Revenue Next 5Y-6.41%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HLBN.DE Yearly Revenue VS EstimatesHLBN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B
HLBN.DE Yearly EPS VS EstimatesHLBN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 2.41 indicates a rather cheap valuation of HLBN.
HLBN's Price/Earnings ratio is rather cheap when compared to the industry. HLBN is cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.06, HLBN is valued rather cheaply.
A Price/Forward Earnings ratio of 17.90 indicates a rather expensive valuation of HLBN.
Based on the Price/Forward Earnings ratio, HLBN is valued a bit more expensive than the industry average as 69.23% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 22.69. HLBN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 2.41
Fwd PE 17.9
HLBN.DE Price Earnings VS Forward Price EarningsHLBN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

69.23% of the companies in the same industry are cheaper than HLBN, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HLBN indicates a somewhat cheap valuation: HLBN is cheaper than 61.54% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.35
EV/EBITDA 8.07
HLBN.DE Per share dataHLBN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

HLBN has an outstanding profitability rating, which may justify a higher PE ratio.
HLBN's earnings are expected to decrease with -10.87% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.33
EPS Next 2Y-20.13%
EPS Next 3Y-10.87%

8

5. Dividend

5.1 Amount

HLBN has a Yearly Dividend Yield of 4.66%, which is a nice return.
The stock price of HLBN dropped by -29.25% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 3.66, HLBN pays a better dividend. On top of this HLBN pays more dividend than 84.62% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, HLBN pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.66%

5.2 History

The dividend of HLBN is nicely growing with an annual growth rate of 39.59%!
Dividend Growth(5Y)39.59%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

11.12% of the earnings are spent on dividend by HLBN. This is a low number and sustainable payout ratio.
DP11.12%
EPS Next 2Y-20.13%
EPS Next 3Y-10.87%
HLBN.DE Yearly Income VS Free CF VS DividendHLBN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B 4B
HLBN.DE Dividend Payout.HLBN.DE Dividend Payout, showing the Payout Ratio.HLBN.DE Dividend Payout.PayoutRetained Earnings

HOLCIM LTD

FRA:HLBN (9/5/2025, 7:00:00 PM)

71.46

+0.66 (+0.93%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)07-31 2025-07-31
Earnings (Next)10-24 2025-10-24
Inst Owners35.55%
Inst Owner ChangeN/A
Ins Owners6.57%
Ins Owner ChangeN/A
Market Cap40.51B
Analysts77.04
Price Target75.8 (6.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.66%
Yearly Dividend3
Dividend Growth(5Y)39.59%
DP11.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.61%
PT rev (3m)-28.08%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-45.47%
EPS NY rev (3m)-45.47%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.04%
Revenue NY rev (3m)-39.93%
Valuation
Industry RankSector Rank
PE 2.41
Fwd PE 17.9
P/S 1.77
P/FCF 10.35
P/OCF 7.58
P/B 2.6
P/tB 5.07
EV/EBITDA 8.07
EPS(TTM)29.64
EY41.48%
EPS(NY)3.99
Fwd EY5.59%
FCF(TTM)6.9
FCFY9.66%
OCF(TTM)9.42
OCFY13.18%
SpS40.32
BVpS27.51
TBVpS14.1
PEG (NY)N/A
PEG (5Y)0.33
Profitability
Industry RankSector Rank
ROA 46.72%
ROE 105.31%
ROCE 13.87%
ROIC 10.52%
ROICexc 12.49%
ROICexgc 18.25%
OM 17.33%
PM (TTM) 71.83%
GM 44.69%
FCFM 17.12%
ROA(3y)5.62%
ROA(5y)4.77%
ROE(3y)11.3%
ROE(5y)9.72%
ROIC(3y)6.46%
ROIC(5y)6.04%
ROICexc(3y)7.58%
ROICexc(5y)7.02%
ROICexgc(3y)13.04%
ROICexgc(5y)11.56%
ROCE(3y)8.52%
ROCE(5y)7.98%
ROICexcg growth 3Y12.63%
ROICexcg growth 5Y13.6%
ROICexc growth 3Y7.66%
ROICexc growth 5Y8.99%
OM growth 3Y4.25%
OM growth 5Y6.16%
PM growth 3Y9.2%
PM growth 5Y5.79%
GM growth 3Y0.94%
GM growth 5Y0.93%
F-Score7
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 2.67
Debt/EBITDA 1.68
Cap/Depr 79.57%
Cap/Sales 6.24%
Interest Coverage 7.36
Cash Conversion 92.82%
Profit Quality 23.83%
Current Ratio 1.49
Quick Ratio 1.21
Altman-Z 3.73
F-Score7
WACC4.56%
ROIC/WACC2.31
Cap/Depr(3y)149.39%
Cap/Depr(5y)143.09%
Cap/Sales(3y)11.07%
Cap/Sales(5y)11.4%
Profit Quality(3y)72.22%
Profit Quality(5y)84.38%
High Growth Momentum
Growth
EPS 1Y (TTM)422.14%
EPS 3Y11.85%
EPS 5Y7.24%
EPS Q2Q%1046.3%
EPS Next Y-39.97%
EPS Next 2Y-20.13%
EPS Next 3Y-10.87%
EPS Next 5Y-5.57%
Revenue 1Y (TTM)-19.77%
Revenue growth 3Y-0.53%
Revenue growth 5Y-0.24%
Sales Q2Q%-38.57%
Revenue Next Year-38.75%
Revenue Next 2Y-20.44%
Revenue Next 3Y-12.87%
Revenue Next 5Y-6.41%
EBIT growth 1Y-15.09%
EBIT growth 3Y3.69%
EBIT growth 5Y5.91%
EBIT Next Year43.61%
EBIT Next 3Y16.89%
EBIT Next 5Y0.89%
FCF growth 1Y835.12%
FCF growth 3Y238.03%
FCF growth 5Y4.99%
OCF growth 1Y15.53%
OCF growth 3Y3.95%
OCF growth 5Y3.27%